Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Tuberous SclerosisAngiolipoma

Interventions

DRUG

everolimus (RAD001)

Subjects will resume the dosing regimen that they were receiving at the completion of the initial RAD001 study.

Trial Locations (1)

Cincinnati Children's Hospital Medical Center, Cincinnati